A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2006
11/23/2006	US20060263358 Method for reducing sepsis or cardiogenic shock associated with myocardial injury
11/23/2006	US20060263357 Anti-CD19 antibody therapy for autoimmune disease
11/23/2006	US20060263356 antibody binding to IL-13R alpha 1, inhibiting IL-13 bioactivity; comprising variable heavy and light chain amino acid sequences CDR1, CDR2, and CDR3; useful in the treatment of asthma and allergic diseases
11/23/2006	US20060263355 Treatment of bone disorders
11/23/2006	US20060263354 Antibodies to myostatin
11/23/2006	US20060263353 untagged antigen is used in conjunction with a polyclonal antibody to isolate cells recognizing the antigen; for cancers, autoimmune or inflammatory disorders
11/23/2006	US20060263352 Quantification of botulinum toxin
11/23/2006	US20060263351 Methods and compositions for protection against thrombolysis associated reperfusion injury
11/23/2006	US20060263350 Combination antihistamine medication
11/23/2006	US20060263349 Pretreatment of a biological sample from an autoimmune disease subject
11/23/2006	US20060263348 Apolipoprotein l-i and/or derivated polypeptide for the treatment of and/or the prevention of diseases induced by trypanosoma
11/23/2006	US20060263343 Molecular dissection of cellular responses to alloantigen or autoantigen in graft rejection and autoimmune disease
11/23/2006	US20060263342 Peptides derived from a protein encoded by a polynucleotide overexpressed in human colon cancer cells; bladder, prostate and breast cancers; antimetastasis agents; diagnosis
11/23/2006	US20060263340 Treating gastrointestinal diseases with modulators of retinoic acid
11/23/2006	US20060263333 Use of myxoma virus for the therapeutic treatment of cancer and chronic viral infection
11/23/2006	DE10344545B9 Genetisch modifiziertes Kapsidprotein des Beak and Feather Disease Virus Genetically modified capsid protein of the Beak and Feather Disease Virus
11/23/2006	CA2853335A1 Hivcon: an hiv immunogen and uses thereof
11/23/2006	CA2609190A1 Methods for treating fibrotic conditions
11/23/2006	CA2609102A1 Int6 protein involved in hypoxia stress induction and use thereof
11/23/2006	CA2609071A1 Method for reducing sepsis or cardiogenic shock associated with myocardial injury
11/23/2006	CA2609043A1 Use of penicillin-binding proteins or polynucleotides or antibodies thereof for preventing or treating bacterial infections
11/23/2006	CA2609038A1 Methods and compositions for immunizing against chlamydia infection
11/23/2006	CA2608979A1 Vaccine composition comprising b-subunit of e. coli heat toxin and an antigen and an adjuvant
11/23/2006	CA2608751A1 Methods for diagnosis and treatment of proliferative disorders mediated by cd40 signaling
11/23/2006	CA2608728A1 Use of tnfa inhibitor for treatment of erosive polyarthritis
11/23/2006	CA2608498A1 Anti-gm-csf antibodies and uses therefor
11/23/2006	CA2608473A1 Combination therapy
11/23/2006	CA2608442A1 Psk- i and its modulators for the treatment/diagnosis of cancer
11/23/2006	CA2608236A1 P53 vaccines for the treatment of cancers
11/23/2006	CA2608193A1 Methods for the rapid expansion of antigen specific t-cells
11/23/2006	CA2607663A1 Compositions and methods for increasing the stability of antibodies
11/23/2006	CA2607305A1 Anti-mesothelin antibodies useful for immunological assays
11/23/2006	CA2607291A1 Compositions and methods for modulating immune responses
11/23/2006	CA2597511A1 Hivcon: an hiv immunogen and uses thereof
11/23/2006	CA2591624A1 Pasteurella multocida vaccine
11/22/2006	EP1724589A2 Methods to identify compounds that modulate rage
11/22/2006	EP1724352A2 Specific nucleic acids and polypeptide from pathogenic strains of Neisseria
11/22/2006	EP1724351A2 Human Kallikrein-like genes
11/22/2006	EP1724349A1 TIE Ligand Homologues
11/22/2006	EP1724342A1 Process for producing erysipelothrix rhusiopathiae surface protective antigen mutant in escherichia coli
11/22/2006	EP1724338A1 Methods for the production of a whole-inactivated West Nile Virus vaccine
11/22/2006	EP1724286A1 Variant CD44 polypeptide, polynucleotides encoding same, antibodies directed there against and method of using same for diagnosing and treating inflammatory diseases
11/22/2006	EP1724282A2 Method for the production of non-immunogenic proteins
11/22/2006	EP1723970A1 Medicinal composition containing cxcr3 inhibitor
11/22/2006	EP1723967A2 Soluble lymphotoxin-beta receptors, anti-lymphotoxin receptor antibodies and anti-lymphotoxin ligand antibodies as therapeutic agents for the treatment of immunological diseases
11/22/2006	EP1723966A2 Oil in water emulsion vaccines
11/22/2006	EP1723965A1 Compositions for antigen-specific induction of immuno-tolerance via oral immunization
11/22/2006	EP1723964A1 Use of penicillin-binding proteins or polynucleotides or antibodies thereof for preventing or treating bacterial infections
11/22/2006	EP1723963A2 Hapten-conjugated tumour cells
11/22/2006	EP1723425A2 Method and device for detecting feline immunodeficiency virus
11/22/2006	EP1723246A1 New expression tools for multiprotein applications
11/22/2006	EP1723178A2 Human g-protein chemokine receptor (ccr5) hdgnr10
11/22/2006	EP1723175A1 Galanin receptors and brain injury
11/22/2006	EP1723170A1 A canine vaccine for protection against ehrlichiosis
11/22/2006	EP1723169A1 Novel tat complexes, and vaccines comprising them
11/22/2006	EP1723168A2 Beak and feather disease virus sequences, compositions and vaccines and the use thereof in therapy, diagnosis and assays
11/22/2006	EP1723167A1 Novel phosphorylated sequences of phosphatase cdc25b, antibodies directed against said sequences and use thereof
11/22/2006	EP1723139A1 Cell targeting conjugates
11/22/2006	EP1722819A2 Method for solubilising peptide mixtures
11/22/2006	EP1722817A1 Antineoplastic combinations of cci-779 and rituximab
11/22/2006	EP1722816A2 Support system in the form of protein-based nanoparticles for the cell-specific enrichment of pharmaceutically active substances
11/22/2006	EP1722815A1 Influenza virus vaccines
11/22/2006	EP1722814A2 Infectious bursal disease virus antigenic isolates and vaccines
11/22/2006	EP1722808A2 Egf receptor epitode peptides and uses thereof
11/22/2006	EP1499392B1 Method and agents for the prevention, inhibition, and therapy of cancers
11/22/2006	EP1370575B1 Synthetic human peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus
11/22/2006	EP1309342B1 Production of a chimeric human papillomavirus
11/22/2006	EP1282444B1 Antithrombotic agents
11/22/2006	EP1263781B1 Viral antigen and vaccine against isav (infectious salmon anaemia virus)
11/22/2006	EP1163522B1 Method for detecting msrv-1 induced superantigen activity in a biological sample
11/22/2006	EP1146899B1 Methods of using neurotrophin 3 (nt-3) for the treatment of gastrointestinal hypomotility disorders
11/22/2006	EP1073462B1 Combined vaccine against Hepatitis A and Hepatitis B
11/22/2006	EP1054895B1 Novel peptide diagnostic reagent and kit for detection of rickettsiosis
11/22/2006	EP1037603B1 Membrane virus host range mutations and their uses as vaccine substrates
11/22/2006	EP1000168B1 A swine hepatitis e virus and uses thereof
11/22/2006	EP1000158B1 Endogenetic retroviral sequences, associated with autoimmune diseases or with pregnancy disorders
11/22/2006	EP0939821B1 G-beta-gamma regulated phosphatidylinositol-3' kinase
11/22/2006	EP0825996B1 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use
11/22/2006	EP0574461B2 High affinity humanized monoclonal antibodies
11/22/2006	CN1867667A Coronavirus, nucleic acid, protein and methods for the generation of vaccine, medicaments and diagnostics
11/22/2006	CN1867589A Synthetic polysaccharide antigens for immunological intervention in disease
11/22/2006	CN1867588A Product comprising a c4bp core protein and a monomeric antigen, and its use
11/22/2006	CN1867586A Multispecific deimmunized CD3-binders
11/22/2006	CN1867356A 抗原递送系统 Antigen delivery system
11/22/2006	CN1867355A New vaccine containing mucosa immunity-inducing adjuvant
11/22/2006	CN1867354A Novel immunogenic compositions for the prevention and treatment of meningococcal disease
11/22/2006	CN1865285A Specific anti-human liver cancer phage single-chain antibody HscFv4-16 gene and its uses
11/22/2006	CN1865281A Specific antibody GB11 T cell epitope peptide for resisting oophoroma and its uses
11/22/2006	CN1864747A Method for preparing active carrier vaccine of avian Chlamydia psittaci
11/22/2006	CN1864746A Gene engineered poly-valence subunit vaccine of Hp AhpC and preparation method thereof
11/22/2006	CN1285613C Antineoplastic rat light chain single domain antibody - Cefuroxime Sodium reinforced fusion protein VL-LDP-AE
11/22/2006	CN1285608C Parainfluenza virus glycoproteins and vaccines
11/22/2006	CN1285606C Nucleotide specific for shigella bodyii 2 O-antigen
11/21/2006	US7138508 Inhibitor protein of the wnt signal pathway
11/21/2006	US7138502 Peptide for use in the prevention and treatment of microorganismal infections
11/21/2006	US7138500 Antibodies to human 4-1BB
11/21/2006	US7138498 DNA (RNA) encoding such chemokine polypeptides and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such chemokine polypeptides for the treatment of
11/21/2006	US7138497 Genetic engineering; crosslinking polypeptide on carrier
11/21/2006	US7138496 Antibody that binds to loop 6 of human CXCR4, especially a single chain antibody
11/21/2006	US7138420 Substituted benzimidazole compounds

1 ... 911 912 913 914 915 916 917 918 919 920 921 922 923 924 925 926 927 928 929 930 931 ... 1823